Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.59 |
| ▸ | CCKAR | P32238 | 7/20 | 0.38 |
| ▸ | CCKBR | P32239 | 7/20 | 0.38 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.37 |
| ▸ | NMT2 | O60551 | 1/20 | 0.36 |
| ▸ | NMT1 | P30419 | 1/20 | 0.36 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.35 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27410394 | 0.99 | GLP1R (0.58) | GLP1RCCKARCCKBRGLO1NMT2 | |
| SCHEMBL27410264 | 0.94 | GLP1R (0.52) | GLP1RNMT2NMT1 | |
| SCHEMBL18885578 | 0.90 | GLP1R (0.62) | GLP1RCCKARCCKBRGLO1 | |
| SCHEMBL22245528 | 0.90 | GLP1R (0.62) | GLP1RCCKARCCKBRGLO1 | |
| SCHEMBL15369019 | 0.90 | GLP1R (0.62) | GLP1RCCKARCCKBRGLO1 | |
| SCHEMBL24899308 | 0.90 | GLP1R (0.62) | GLP1RCCKARCCKBRGLO1 | |
| SCHEMBL22245502 | 0.90 | GLP1R (0.62) | GLP1RCCKARCCKBRGLO1 | |
| SCHEMBL25454272 | 0.90 | GLP1R (0.62) | GLP1RCCKARCCKBRGLO1 | |
| SCHEMBL21242756 | 0.90 | GLP1R (0.62) | GLP1RCCKARCCKBRGLO1 | |
| SCHEMBL23081524 | 0.90 | GLP1R (0.62) | GLP1RCCKARCCKBRGLO1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2552950-A1 | NOVEL GLUCAGON ANALOGUES | Novo Nordisk A/S (DK) | 2013-02-06 | — | — | EP | claimed |
| WO-2011117415-A1 | NOVEL GLUCAGON ANALOGUES | NOVO NORDISK A/S (DK) | 2011-09-29 | — | — | WO | claimed |
| EP-2552950-A1 | NOVEL GLUCAGON ANALOGUES | Novo Nordisk A/S (DK) | 2013-02-06 | — | — | EP | disclosed |
| WO-2011117415-A1 | NOVEL GLUCAGON ANALOGUES | NOVO NORDISK A/S (DK) | 2011-09-29 | — | — | WO | disclosed |
| WO-2011117415-A1 | NOVEL GLUCAGON ANALOGUES | NOVO NORDISK A/S (DK) | 2011-09-29 | — | — | WO | disclosed |